ライフサイエンスコーパス: magnetic resonance

1 on using the gold standard of cardiovascular magnetic resonance.

2 ood of adverse cardiac remodeling by cardiac magnetic resonance.

3 Proton Nuclear Magnetic Resonance ((1)H NMR) was employed to study mono

4 The proton nuclear magnetic resonance analysis indicated that all of the pr

5 e using a combination of solid state nuclear magnetic resonance and dielectric spectroscopies, neutro

6 for post-mortem, pharmacological, functional magnetic resonance and molecular imaging studies of dopa

7 the recovered product by solid-state nuclear magnetic resonance and neutron pair distribution functio

8 report the measurement of optically detected magnetic resonance and the demonstration of coherent con

9 raction, solid fat content by pulsed nuclear magnetic resonance and thermal behaviour by differential

10 We perform nuclear Magnetic Resonance and thermodynamic stability measureme

11 eeze-trapping x-ray crystallography, nuclear magnetic resonance, and computational techniques reveal

12 ic effects were quantified by phase contrast magnetic resonance angiography at baseline and after 120

13 titative flow was measured by phase-contrast magnetic resonance angiography of the cerebropetal vesse

14 t was identified by purification and nuclear magnetic resonance as syringyl lactic acid hexoside.

15 ate gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle insertion site

16 g to the simulated results, the electric and magnetic resonances at visible wavelengths are obtained

17 Cardiovascular magnetic resonance based on the Lake Louise Criteria is

18 ope tracer experiments combined with nuclear magnetic resonance-based metabolic analysis demonstrate

19 novel monetary reward task during functional magnetic resonance brain imaging, the authors tested how

20 Cardiovascular magnetic resonance (CMR) can detect morphological, funct

21 gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging can be used to evaluate

22 of rate control, patients underwent cardiac magnetic resonance (CMR) to assess LVEF and late gadolin

23 Secondary end points included cardiac magnetic resonance-determined myocardial salvage and cre

24 Magnetic resonance elastography (MRE) is a promising tec

25 ciated with reductions in liver stiffness on magnetic resonance elastography, collagen content and lo

26 etreatment and posttreatment liver biopsies, magnetic resonance elastography, magnetic resonance imag

27 any kind (e.g., UV-vis, infrared, microwave, magnetic resonance, etc.).

28 All magnetic resonance findings were related to the presence

29 ange 1-3 GHz have been measured based on the magnetic resonance frequency of the transmission loss of

30 Cardiac magnetic resonance has unparalleled tissue characterizat

31 Magnetic resonance images and core biopsy findings.

32 ported executive functioning, and functional magnetic resonance images during 1-back and 2-back tasks

33 Their angiograms and magnetic resonance images were evaluated, with two evalu

34 d with voxel-based morphometry of anatomical magnetic resonance images, are commonly interpreted to r

35 Cardiac magnetic resonance imaging (CMR) provides both cardiac a

36 global longitudinal strain, -21.5%), cardiac magnetic resonance imaging (CMR, as part of an ongoing s

37 Cardiac magnetic resonance imaging (cMRI) has become the non-inv

38 e, we applied 7 T high-resolution functional magnetic resonance imaging (fMRI) alongside a perceptual

39 Resting-state functional magnetic resonance imaging (fMRI) and (1)H magnetic reso

40 Combining functional magnetic resonance imaging (fMRI) and magnetoencephalogr

41 Herein we explored the value of functional magnetic resonance imaging (fMRI) as an objective measur

42 arning task during acquisition of functional magnetic resonance imaging (fMRI) in a 2-drug, double-bl

43 By using functional magnetic resonance imaging (fMRI) in a large multisite s

44 We measured brain activity with functional magnetic resonance imaging (fMRI) in volunteers as they

45 We used functional magnetic resonance imaging (fMRI) methods uniquely power

46 we provide new evidence based on functional magnetic resonance imaging (fMRI) of the macaque indicat

47 -life sounds from high-resolution functional magnetic resonance imaging (fMRI) response patterns in t

48 ron emission tomography (PET) and functional magnetic resonance imaging (fMRI) scans while performing

49 xygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) signal response to vis

50 Functional magnetic resonance imaging (fMRI) studies indicate that

51 Functional magnetic resonance imaging (fMRI) studies performed duri

52 Major advances in resting-state functional magnetic resonance imaging (fMRI) techniques in the last

53 We used functional magnetic resonance imaging (fMRI) to investigate how the

54 Here, we combined human functional magnetic resonance imaging (fMRI) with a previously deve

55 blood flow (CBF) was measured by functional magnetic resonance imaging (fMRI), and neuronal precurso

56 g-state networks identified using functional magnetic resonance imaging (fMRI), determining their mom

57 s and 18 good sleepers (GS) using functional magnetic resonance imaging (fMRI).

58 23) during arterial spin labeling functional magnetic resonance imaging (fMRI).

59 low (CBF) can be measured noninvasively with magnetic resonance imaging (MRI) and abnormalities in re

60 Integration of magnetic resonance imaging (MRI) and other imaging modal

61 of the same UCNP@mSiO2-Dopa nanoplatform for magnetic resonance imaging (MRI) and x-ray computed tomo

62 Perivascular spaces that are visible on magnetic resonance imaging (MRI) are a neuroimaging mark

63 Multiphasic computed tomography (CT) and magnetic resonance imaging (MRI) are both used for nonin

64 24 months after randomization and changes on magnetic resonance imaging (MRI) at 6 months and 24 mont

65 Multiparametric Magnetic Resonance Imaging (MRI) can provide detailed in

66 Injectable Magnetic Resonance Imaging (MRI) contrast agents have be

67 brain atlases extend analysis of functional magnetic resonance imaging (MRI) data by delineating reg

68 mical precision to structural and functional magnetic resonance imaging (MRI) data, we aimed to ident

69 Magnetic resonance imaging (MRI) does not offer sufficie

70 Presentation of magnetic resonance imaging (MRI) findings in pregnant wo

71 Magnetic resonance imaging (MRI) has been used for many

72 In particular, magnetic resonance imaging (MRI) is critical for visuali

73 visibility of perivascular spaces (PVSs) on magnetic resonance imaging (MRI) is hypothesized to repr

74 diac diseases have been previously linked to magnetic resonance imaging (MRI) manifestations of cereb

75 EG) measures of neural processing speed with magnetic resonance imaging (MRI) measures of white and g

76 ensional cell culture served as a functional magnetic resonance imaging (MRI) phantom for sodium mult

77 ng of positron emission tomography (PET) and magnetic resonance imaging (MRI) scans acquired in a tot

78 Structural T1-weighted brain magnetic resonance imaging (MRI) scans from 2148 MDD pat

79 ctober 20, 2014, and who had a pretransplant magnetic resonance imaging (MRI) severity score of less

80 BACKGROUND & AIMS: Magnetic resonance imaging (MRI) techniques and ultrasou

81 resent multicenter study, we used structural magnetic resonance imaging (MRI) to compare 103 children

82 control (HC) subjects, with high-resolution magnetic resonance imaging (MRI) to estimate NAc volumes

83 approaches (photoacoustic imaging (PAI) and magnetic resonance imaging (MRI)) to detect melanin indu

84 trasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), which revealed bilater

85 Patients with recent magnetic resonance imaging (MRI)-documented lacunar infa

86 en a contraindication for the performance of magnetic resonance imaging (MRI).

87 mm or greater on computed tomography (CT) or magnetic resonance imaging (MRI).

88 maly which can be very well characterized by magnetic resonance imaging (MRI).

89 vide high sensitivity contrast for molecular magnetic resonance imaging (MRI).

90 Smell Identification Test (B-SIT), underwent magnetic resonance imaging (n = 829) to assess a composi

91 ces in resting-state functional connectivity magnetic resonance imaging (rs-fcMRI) and the distinctiv

92 AND Fifty patients underwent cardiovascular magnetic resonance imaging acutely (24-72 hours) and at

93 tly from a hippocampal-entorhinal functional magnetic resonance imaging adaptation signal in a situat

94 Maximum LA volume was determined by cardiac magnetic resonance imaging among 748 participants in the

95 and performed strategy-dependent functional magnetic resonance imaging analyses.

96 Recently, a diffusion magnetic resonance imaging analysis technique using a bi

97 In this study, we use functional magnetic resonance imaging and a public pledge for futur

98 ide] in humans with resting-state functional magnetic resonance imaging and clustering methods.

99 connectivity using resting-state functional magnetic resonance imaging and diffusion-weighted imagin

100 s in the brain's blood flow using functional magnetic resonance imaging and electrical activity using

101 We used resting-state functional magnetic resonance imaging and functional connectivity a

102 Participants underwent magnetic resonance imaging and positron emission tomogra

103 dy fat and intrahepatic fat were detected by magnetic resonance imaging and spectroscopy, respectivel

104 and regional brain volumes using structural magnetic resonance imaging at 1 and 2 years of age.

105 Patients underwent cardiac magnetic resonance imaging at baseline and post-cycle 17

106 genation by 3-T blood oxygen level-dependent magnetic resonance imaging before and 3 months after PTR

107 hod, was applied to resting-state functional magnetic resonance imaging data in 66 smokers and 92 non

108 Histopathology and magnetic resonance imaging demonstrated that SEB mediate

109 a patient with TUBB4A Asn414Lys mutation and magnetic resonance imaging evidence of severe hypomyelin

110 ltrasonography detected an adrenal mass, and magnetic resonance imaging excluded common lesions of th

111 l facial appearance and characteristic brain magnetic resonance imaging findings.

112 M rats showed lower resting-state functional magnetic resonance imaging functional connectivity in co

113 Cardiovascular magnetic resonance imaging has become an indispensable t

114 Cardiovascular magnetic resonance imaging has become the gold standard

115 ty cues (stimulus context) during functional magnetic resonance imaging in 48 male and female healthy

116 ric assessment, and resting-state functional magnetic resonance imaging in a cross-sectional design.

117 Here 21 healthy men underwent functional magnetic resonance imaging in a double-blind, placebo-co

118 Using whole-brain functional magnetic resonance imaging in macaque monkeys, we discov

119 fects of DBS during resting-state functional Magnetic Resonance Imaging in ten patients with Parkinso

120 We examined the right ventricle with cardiac magnetic resonance imaging in the same cohorts.

121 Functional magnetic resonance imaging included a resting state and

122 Magnetic resonance imaging is the best imaging modality

123 ain network architecture, employing advanced magnetic resonance imaging methods that quantify biomark

124 hat are not accessible with other structural magnetic resonance imaging methods.

125 ical memory recall with real-time functional magnetic resonance imaging neurofeedback (rtfMRI-nf) tra

126 Cardiac magnetic resonance imaging provides data that are both c

127 biomarkers of AD pathology, and quantitative magnetic resonance imaging relaxometry measures, includi

128 To report the 2-year clinical and cardiac magnetic resonance imaging results and their modificatio

129 Functional magnetic resonance imaging revealed that the same PSD3 h

130 nally, we discuss how optogenetic functional magnetic resonance imaging reveals global scale circuit

131 >/=2 weeks who had at least one postbaseline magnetic resonance imaging scan that was preceded by a 3

132 nts with CIS underwent a lumbar puncture and magnetic resonance imaging scan within 6 months after fi

133 e at birth, infant sex, and postnatal age at magnetic resonance imaging scan.

134 ts with a single ventricle were studied with magnetic resonance imaging scans immediately prior to bi

135 cal harms, defined as computed tomography or magnetic resonance imaging scans, biopsies, or other pro

136 n visual inspection of individual structural magnetic resonance imaging scans.

137 48 months by using the modified Whole-Organ Magnetic Resonance Imaging Score (WORMS).

138 In neonates, magnetic resonance imaging should be performed as the me

139 so associated with a differential functional magnetic resonance imaging signal in the PFC during a Go

140 we used data from two independent functional magnetic resonance imaging studies [n = 108 males and n

141 over Days 0-3 after initial haemorrhage and magnetic resonance imaging studies were performed at app

142 Cross-sectional functional magnetic resonance imaging study in a large, well-charac

143 end points, such as volumetric measurement, magnetic resonance imaging T2 weighted mapping, nuclear

144 The functional magnetic resonance imaging tasks were designed to differ

145 Quantitative volumetric magnetic resonance imaging techniques have provided limi

146 l highlight some recent novel cardiovascular magnetic resonance imaging techniques, concepts, and app

147 d (3)He are gases used as contrast media for magnetic resonance imaging that provide measurement of d

148 perivascular gadolinium enhancing lesions on magnetic resonance imaging that were discriminated from

149 We yoked anatomical brain magnetic resonance imaging to a randomized, double-blind

150 A levels as well as resting-state functional magnetic resonance imaging to assess sensorimotor networ

151 OS patients with hepatic iron >50 mumol/g at magnetic resonance imaging to compare the metabolic and

152 Participants also underwent magnetic resonance imaging to determine hippocampal volu

153 riction of pregnant mothers and used cardiac magnetic resonance imaging to evaluate offspring heart f

154 ned resting-state and task-driven functional magnetic resonance imaging to examine how flexible, task

155 We used functional magnetic resonance imaging to examine whether motivation

156 this hypothesis using ultra-fast functional magnetic resonance imaging to measure BOLD activity at p

157 prospectively evaluated clinically and with magnetic resonance imaging to quantify iron through R2*

158 nt late gadolinium enhancement (LGE)-cardiac magnetic resonance imaging to quantify LA fibrosis sever

159 ippocampus-selective behavioral testing, and magnetic resonance imaging tractography to examine the c

160 hippocampal efferent pathways documented by magnetic resonance imaging tractography.

161 In another experiment, brain functional magnetic resonance imaging was conducted while participa

162 Cardiac magnetic resonance imaging was repeated at 3 months.

163 Magnetic resonance imaging was used to continuously moni

164 schizophrenia and healthy controls by using magnetic resonance imaging were selected.

165 e to support the prognostic value of cardiac magnetic resonance imaging with late gadolinium enhancem

166 aphic coronary angiogram, and cardiovascular magnetic resonance imaging with late gadolinium enhancem

167 -hour BP, and left ventricular mass (cardiac magnetic resonance imaging).

168 x undergoing AVR underwent echocardiography, magnetic resonance imaging, a 6-minute walk test, and me

169 Using (23)sodium-magnetic resonance imaging, a technique recently develop

170 Using functional magnetic resonance imaging, neural response was measured

171 After magnetic resonance imaging, the rats were catheterized,

172 ve electrodes, carbon fiber amperometry, and magnetic resonance imaging, we monitored stimulus-couple

173 Using functional magnetic resonance imaging, we show that children as you

174 ycerin (7.2 mg over 2 days) on early cardiac magnetic resonance imaging-assessed infarct size.

175 Participants included term neonates with magnetic resonance imaging-confirmed NHS including prima

176 Magnetic resonance imaging-derived cBF volumes were stud

177 r biopsies, magnetic resonance elastography, magnetic resonance imaging-estimated proton density fat

178 nd to be better than that for (i) functional magnetic resonance imaging-guided regions; (ii) a region

179 index, 0.2-96.6 events/h) were evaluated by magnetic resonance imaging.

180 es in IUGR young adult baboons using cardiac magnetic resonance imaging.

181 al lesions were excluded based on structural magnetic resonance imaging.

182 ients showed a new medullary lesion on brain magnetic resonance imaging.

183 and other structural imaging series using 3T magnetic resonance imaging.

184 y, and brain atrophy was detected by ex vivo magnetic resonance imaging.

185 al infarction underwent both ECG and cardiac magnetic resonance imaging.

186 Disc quality was followed up by magnetic resonance imaging.

187 and S1 at ultra high-field (7 T) functional magnetic resonance imaging.

188 d by masked review of computed tomography or magnetic resonance imaging.

189 itron emission tomography and cardiovascular magnetic resonance imaging.

190 ohistochemistry and resting-state functional magnetic resonance imaging; and investigated main behavi

191 limitations to measuring strain with cardiac magnetic resonance in the acute setting, and knowledge g

192 rcise testing, echocardiography, and cardiac magnetic resonance including cardiac (31)P-spectroscopy.

193 d microvascular obstruction (MVO) at cardiac magnetic resonance is significantly different.

194 We used cardiac magnetic resonance measurements of extracellular volume

195 using high-accuracy (75)As and (51)V nuclear magnetic resonance measurements, we investigate an elect

196 Here we focus on applications of magnetic resonance metabolomics for quantifying circulat

197 s were quantified by high-throughput nuclear magnetic resonance metabolomics.

198 y echocardiography, electrocardiography, and magnetic resonance microscopy imaging.

199 ding whether the relevant coupling mode is a magnetic resonance mode or an oxygen buckling phonon mod

200 performance and examination success rate of magnetic resonance (MR) elastography and vibration-contr

201 2D spin-echo (SE) echo-planar imaging (EPI) magnetic resonance (MR) elastography for measurement of

202 consecutive female patients referred for 3-T magnetic resonance (MR) evaluation of known or suspected

203 op and evaluate an examination consisting of magnetic resonance (MR) fingerprinting-based T1, T2, and

204 near finite element analysis method by using magnetic resonance (MR) images for the assessment of the

205 markers derived from standard cardiovascular magnetic resonance (MR) images for their incremental dia

206 ic brain tumour model that is extracted from magnetic resonance (MR) images.

207 ntate nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images.

208 e pediatric brain on nonenhanced T1-weighted magnetic resonance (MR) images.

209 erosis, 40 participants with IPH at baseline magnetic resonance (MR) imaging (53 carotids with IPH) w

210 Magnetic resonance (MR) imaging (T1-weighted and diffusi

211 est whether MPO-Gd, an activatable molecular magnetic resonance (MR) imaging agent specific for myelo

212 Purpose To analyze claustrophobia during magnetic resonance (MR) imaging and to explore the poten

213 vestigate the utility and accuracy of breast magnetic resonance (MR) imaging as a supplemental screen

214 sites, a total of 44 volunteers underwent a magnetic resonance (MR) imaging examination in which ima

215 aphy (US) followed by conditional unenhanced magnetic resonance (MR) imaging for the imaging work-up

216 ieved with abbreviated biparametric prostate magnetic resonance (MR) imaging in comparison with full

217 Brain lesion count was recorded from brain magnetic resonance (MR) imaging in patients with fCCM.

218 ial-enhanced spectral mammography and breast magnetic resonance (MR) imaging in the detection of inde

219 se To investigate whether combining multiple magnetic resonance (MR) imaging modalities such as T1-we

220 Ferumoxytol-enhanced magnetic resonance (MR) imaging of donor-matched and mis

221 ce sequentially underwent dual-energy CT and magnetic resonance (MR) imaging of the axial skeleton.

222 ive dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging of transient bone marrow

223 the performance of tumor subtype and various magnetic resonance (MR) imaging parameters in the assess

224 T) in an integrated time-of-flight (TOF) PET/magnetic resonance (MR) imaging system.

225 26 patients who did not) who underwent brain magnetic resonance (MR) imaging with a mixed fast spin-e

226 ith reported knee trauma who underwent 1.5-T magnetic resonance (MR) imaging within 90 days of knee t

227 raphy, dynamic contrast agent-enhanced (DCE) magnetic resonance (MR) imaging, and biannual automated

228 vestigate, by using resting-state functional magnetic resonance (MR) imaging, cerebellar dentate nucl

229 sed pulmonary hypertension underwent cardiac magnetic resonance (MR) imaging, right-sided heart cathe

230 with that of ultrasonography (US) and other magnetic resonance (MR) imaging-based parameters.

231 break (DSB) formation in patients undergoing magnetic resonance (MR) imaging.

232 oma and suspected progression at posttherapy magnetic resonance (MR) imaging.

233 (90 kV and 150 kV with a tin filter) and 3-T magnetic resonance (MR) imaging.

234 state cancers missed at multiparametric (MP) magnetic resonance (MR) imaging.

235 We report a Co2-based magnetic resonance (MR) probe that enables the ratiometr

236 cokinetics of a new type I collagen-targeted magnetic resonance (MR) probe, CM-101, and to assess its

237 e-dimensional gamma-aminobutyric acid-edited magnetic resonance (MR) spectroscopic imaging in subject

238 nd hyperpolarized carbon 13 ((13)C)-pyruvate magnetic resonance (MR) spectroscopy, can serve as indic

239 brosis, inflammation, and steatosis with the magnetic resonance (MR) viscoelastic and diffusion param

240 METHODS AND We performed cardiac magnetic resonance myocardial feature tracking in 22 pat

241 nerve lesions in multiple sclerosis (MS) by magnetic resonance neurography (MRN).

242 Enzymatic assay and nuclear magnetic resonance (NMR) analysis demonstrated that EYA1

243 meters, near-infra red data and (1)H nuclear magnetic resonance (NMR) fingerprints, obtained on mono-

244 Nuclear magnetic resonance (NMR) profiles were analyzed by using

245 e (1D) and two dimensional (2D) (1)H Nuclear Magnetic Resonance (NMR) relaxometry.

246 Using them as nuclear magnetic resonance (NMR) sensitive nanoprobes adds anoth

247 tionally rich information content of nuclear magnetic resonance (NMR) spectra is routinely used to id

248 two-dimensional solid-state (77) Se nuclear magnetic resonance (NMR) spectroscopic study of the chai

249 tract and structurally elucidated by Nuclear Magnetic Resonance (NMR) spectroscopy and mass spectrome

250 ging and two-dimensional solid-state nuclear magnetic resonance (NMR) spectroscopy, we show that mine

251 In this study, nuclear magnetic resonance (NMR) spectroscopy-based metabolomic

252 ulations, in combination with (7) Li nuclear magnetic resonance (NMR) spectroscopy.

253 C-HRMS), LC-tandem MS (LC-MS/MS) and nuclear magnetic resonance (NMR) spectroscopy.

254 Here, we develop a convenient (17)O nuclear magnetic resonance (NMR) strategy to distinguish oxide n

255 Nuclear magnetic resonance (NMR) titrations, potentiometric sand

256 We demonstrate using nuclear magnetic resonance (NMR)-based relaxation dispersion tha

257 e prospectively recruited for cardiovascular magnetic resonance performed before PVR (pPVR), immediat

258 ecanalization of the culprit artery, cardiac magnetic resonance performed during index hospitalizatio

259 e, such as X-ray crystallography and nuclear magnetic resonance (primary techniques) and a broad rang

260 lume measures acquired during cardiovascular magnetic resonance promises to transform clinical care b

261 nvestigated using time-domain proton nuclear magnetic resonance relaxometry, and related to their hyd

262 In this study, identical magnetic resonance scans using arterial spin labeling (A

263 quences for the analysis and design of novel magnetic resonance shift and optical emission probes tha

264 olite measures were quantified using nuclear magnetic resonance spectrometry.

265 (1)H Magnetic Resonance Spectroscopic imaging (SI) is a power

266 onal dynamic dual-agent hyperpolarized (13)C magnetic resonance spectroscopic imaging approach with (

267 be measured in vivo using non-invasive (13)C magnetic resonance spectroscopic imaging, is increased i

268 ues used to study cerebral metabolism, (13)C magnetic resonance spectroscopy (MRS) allows following t

269 l magnetic resonance imaging (fMRI) and (1)H magnetic resonance spectroscopy (MRS) data were obtained

270 We assessed whether Glu measured with magnetic resonance spectroscopy (MRS) was associated wit

271 Using (1)H Nuclear Magnetic Resonance spectroscopy (NMR) and Gas Chromatogr

272 Liquid-state, one-dimension (31)P nuclear magnetic resonance spectroscopy (NMR) has greatly advanc

273 Here we show, using nuclear magnetic resonance spectroscopy and density functional t

274 1)P solid-state magic-angle-spinning nuclear magnetic resonance spectroscopy and differential scannin

275 cts were analysed using 600 MHz (1)H Nuclear Magnetic Resonance spectroscopy and Ultra-Performance Li

276 constant using (31)P magnetization transfer magnetic resonance spectroscopy as described previously.

277 Proton magnetic resonance spectroscopy at 7T was performed in 2

278 in patients with schizophrenia using proton magnetic resonance spectroscopy at 7T, which allows sepa

279 We perform (1)H and (19)F nuclear magnetic resonance spectroscopy at room temperature in m

280 Nuclear magnetic resonance spectroscopy demonstrated that the N-

281 While X-ray crystallography and nuclear magnetic resonance spectroscopy have revealed the struct

282 Following baseline proton magnetic resonance spectroscopy scans targeting the mPFC

283 groups were brought back to undergo outcome magnetic resonance spectroscopy scans, which were identi

284 ery and neuroimaging that included optimized magnetic resonance spectroscopy to measure anterior cing

285 We used pulmonary gas exchange and (31) P magnetic resonance spectroscopy to measure whole-body VO

286 dults (N = 48; age range, 50-79 years) using magnetic resonance spectroscopy to quantify GABA levels

287 c content measured in lymphocytes by nuclear magnetic resonance spectroscopy was altered in septic pa

288 sient HG bps, we used solution-state nuclear magnetic resonance spectroscopy, including measurements

289 as measured by ex vivo (1)H-[(13)C]-nuclear magnetic resonance spectroscopy.

290 ate of glutamate and glutamine) levels using magnetic resonance spectroscopy.

291 ned using (1)H and (7)Li solid-state nuclear magnetic resonance spectroscopy.

292 equential (2)H and (31)P solid-state nuclear magnetic resonance spectroscopy.

293 ing solid-state magic angle spinning nuclear magnetic resonance spectroscopy.

294 Nuclear magnetic resonance structural studies reveal that Hi1a c

295 Here, we describe crystal and nuclear magnetic resonance structures of KaiB-KaiC,KaiA-KaiB-Kai

296 Nuclear magnetic resonance studies confirmed that the capsule of

297 By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other

298 This review deals with the use of Nuclear Magnetic Resonance techniques to monitor the behavior of

299 es, their poor responsivities toward nuclear magnetic resonance, ultraviolet/visible, and infrared an

300 t-off value (5%) used to define steatosis by magnetic resonance was derived from studies that did not